Aug. 8, 2025
| Today’s news and insights for medtech leaders
A problem with speakers in Tandem’s t:slim X2 insulin pumps can cause insulin delivery to stop, the company said.
|
The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.
|
A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.
|
Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.
|
CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million to $80 million.
|
From Our Library
Playbook
Custom content for Medrio
|
View all resources
What We're Reading
Fierce Biotech
|
Healthcare Dive
|
Supply Chain Dive
|
Dive Into a Topic
|